secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2025-01-29T23:59:59+00:00
Accession:  0001104659-25-007049
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS Life Sciences raises $25M in registered direct offering of common stock and warrants
--------------------------------------------------------------------------------

- 19,685,040 shares (or pre-funded warrants) plus 19,685,040 common warrants at $1.27 combined price.
- Warrants exercisable at $1.20 per share, expire 5 years from issuance.
- Gross proceeds ~$25M; net proceeds for working capital and general corporate purposes.
- Offering priced at-the-market under Nasdaq rules; expected to close Jan 29, 2025.
- Single healthcare-focused institutional investor; A.G.P. and Maxim as placement agents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465925007049/0001104659-25-007049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465925007049/tm254790d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-007049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer